HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases.

Abstract
A large chikungunya virus (CHIKV) outbreak emerged in 2005-2006 in the Indian Ocean islands, including Comoros, Mayotte, Mauritius, the Seychelles, and particularly in Reunion Island where 35% of 770,000 inhabitants were infected in 6 months. More recently, circulation of the virus has been documented in Madagascar and in India where CHIKV is spreading rapidly. CHIKV-infected visitors have returned home to nonendemic regions from these islands. We conducted a 14-month prospective observational study on the clinical aspects of CHIKV infection imported to Marseilles, France, in travelers returning from the Indian Ocean islands. A total of 47 patients have been diagnosed with imported CHIKV infection confirmed by serology, reverse transcription-polymerase chain reaction, and/or viral culture. At the early stage of the disease (within 10 days of the disease onset), fever was present in 45 of 47 patients. A rash was present in the first week in 25 cases. All patients suffered with arthritis. The most frequently affected joints were fingers, wrists, toes, and ankles. Eight patients were hospitalized during the acute stage, including 2 severe life-threatening cases. A total of 38 patients remained symptomatic after the tenth day with chronic peripheral rheumatism, characterized by severe joint pain and multiple tenosynovitis, with a dramatically limited ability to ambulate and carry out activities in daily life. Three patients were hospitalized at this stage for severe persistent handicap. Follow-up demonstrated slow improvement in joint pain and stiffness despite symptomatic treatment, mainly antiinflammatory and analgesic drugs. In the current series we describe 2 stages of the disease, an initial severe febrile and eruptive polyarthritis, followed by disabling peripheral rheumatism that can persist for months. We point out the possibility of transitory peripheral vascular disorders during the second stage and the occasional benefit of short-term corticosteroids. As CHIKV could spread throughout the world, all physicians should be prepared to encounter this arboviral infection.
AuthorsFabrice Simon, Philippe Parola, Marc Grandadam, Sabrina Fourcade, Manuela Oliver, Philippe Brouqui, Pierre Hance, Philippe Kraemer, Anzime Ali Mohamed, Xavier de Lamballerie, Rémi Charrel, Hugues Tolou
JournalMedicine (Medicine (Baltimore)) Vol. 86 Issue 3 Pg. 123-137 (May 2007) ISSN: 0025-7974 [Print] United States
PMID17505252 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • DNA, Viral
Topics
  • Adolescent
  • Adult
  • Aged
  • Alphavirus Infections (diagnosis, epidemiology)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Arthritis, Infectious (drug therapy, virology)
  • Chikungunya virus (genetics, isolation & purification)
  • Child
  • Child, Preschool
  • Communicable Diseases, Emerging (epidemiology)
  • DNA, Viral (analysis)
  • Disease Outbreaks
  • Female
  • Humans
  • Indian Ocean Islands (epidemiology)
  • Infant
  • Male
  • Middle Aged
  • Prospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • Travel

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: